Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
09/2010
09/08/2010CN101822699A Traditional Chinese medicine for treating psoriasis and preparation method thereof
09/08/2010CN101822696A Medicine composite for treating burn and scald and preparation method thereof
09/08/2010CN101822638A Nano-emulsion of stilbene compound and preparation method thereof
09/08/2010CN101822633A Fig Chinese medicinal skin care milk and preparation method thereof
09/08/2010CN101822628A Special pure Chinese medicine hair restoring and curing essence for men and preparation method thereof
09/08/2010CN101822621A External solution for eliminating body odor
09/08/2010CN101822466A Health-care mattress
09/08/2010CN101658610B Chinese materia medica preparation for treating bedsore and preparation method thereof
09/08/2010CN101574431B Drug for treating vitligo
09/08/2010CN101249200B Chinese medicine lotion preparation for curing shallow wounds
09/08/2010CN101224281B Chinese traditional medicine preparation for purulent inflammation of skin
09/08/2010CN101181444B Multi-efficacy externally used drug as well as method for preparing immersion agent thereof
09/08/2010CN101167857B Traditional Chinese medicine paste for treating burn and scald
09/08/2010CN101167855B Medicine for treating tinea pedis and tinea manuum
09/08/2010CN101134094B Liniment for treating skin pruritus, eczema and scaly tetter
09/08/2010CN101112526B Chinese traditional medicine prescription for treating chloasma administered alternately according to menstrual cycle
09/08/2010CN101099735B Wide-spectrum high-efficient microorganism killing agent
09/08/2010CN101077360B Medicinal composition for treating sugar diabetes skin ulcer and preparation method thereof
09/08/2010CN101036720B External Chinese traditional medicine compound for curing tineamanuum
09/08/2010CN101032573B Medicine for treating psoriasis and its preparing process
09/08/2010CN101028375B Oral externally-applied Chinese medicinal composition for treating leucoderma
09/08/2010CN101014329B Pharmaceutical composition for preventing or treating rejection reaction of organ or tissue transplant, host resistance reaction of implant in bone marrow transplantation
09/07/2010US7790916 therapy of NF-kappaB mediated diseases; mitochondrial diseases; transplantation medicine
09/07/2010US7790902 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents
09/07/2010US7790851 heterodimeric receptor complex comprising an isolated soluble cytokine receptor and a soluble zcytor11 polypeptide; for use in treatment of cell proliferative, inflammatory and immune disorders
09/07/2010US7790771 Chloramine-t as a wound healing agent and viricide, particularly the herpes and varicella viruses; pruritus; skin disorders; diseasesof the mucous membranes, organs and tissues; with the exception of treatment of retro-viral (HIV) diseases; dermatitis; acne; psoriasis; side effect reduction
09/07/2010US7790736 Dipeptidyl peptidase inhibitors
09/07/2010US7790723 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
09/07/2010US7790700 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
09/07/2010US7790692 Improving tissue survival; methods for enhancing organ transplant, musculocutaneous flap or skin graft survival by administering a nucleic acid sequence encoding hepatocyte growth factor; neovascularization; surgery; tissue-targeted therapy
09/07/2010US7790674 Treating inflammatory disease; use in combination with other antiinflammatory agents such as anakinra; rheumatoid arthritis for example; Ang-2 inhibitor peptides of amino acid sequence WDPWT
09/07/2010US7790165 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
09/07/2010US7790158 Using tumor necrosis factors specific immunoglobulins to treat rheumatoid arthritis, diabetes type I, multiple sclerosis, and inflammatory bowel diseases
09/07/2010CA2562801C Pharmaceutical composition for treating hair loss and benign prostatic hyperplasia
09/07/2010CA2493680C Condensed heterocyclic pyrazole derivatives as kinase inhibitors
09/07/2010CA2490326C Photodynamic therapy for vascular diseases
09/02/2010WO2010099319A2 Composition and methods for clotting blood
09/02/2010WO2010098230A1 Transdermal preparation
09/02/2010WO2010097788A2 Visfatin therapeutic agents for the treatment of acne and other conditions
09/02/2010WO2010097468A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097467A1 N-phenylacetamide derivatives, which inhibit the enzyme soat-1 and pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097381A1 Uses of nk receptor antagonists
09/02/2010WO2010097334A1 Drug combinations containing pde4 inhibitors and nsaids
09/02/2010WO2010097332A1 Drug combinations containing pde4 inhibitors and nsaids
09/02/2010WO2010097172A1 New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
09/02/2010WO2010096868A1 Topical foam composition
09/02/2010WO2010096853A1 Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptor
09/02/2010WO2010066914A3 Remedies for pemphigus containing anti fas ligand antibodies
09/02/2010WO2009094426A8 13,13-dimethyl-des-c,d analogs of 1alpha, 25-dihydroxy-19-nor-vitamin d3 compounds and topical composition dosage forms and methods of treating skin conditions thereof
09/02/2010WO2009074797A8 Methods for inhibiting scarring
09/02/2010US20100222591 New Compounds
09/02/2010US20100222431 Novel phenylurea inhibitors of the soat-1 enzyme and pharmaceutical/cosmetic compositions comprised thereof
09/02/2010US20100222419 Method to inhibit cell growth using oligonucleotides
09/02/2010US20100222403 Micogel Topical Formulations
09/02/2010US20100222371 Prevention of surgical adhesions
09/02/2010US20100222368 N-(Heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives, preparation and therapeutic use thereof
09/02/2010US20100222366 Piperidine derivatives as modulators of chemokine receptor activity
09/02/2010US20100222364 Pharmaceutical composition for treating hair loss and benign prostatic hyperplasia
09/02/2010US20100222362 N-oxides of n-phenyl-2-pyramidine-amine derivatives
09/02/2010US20100222340 SUBSTITUTED PYRIDO [1,2-a] ISOQUINOLINE DERIVATIVES
09/02/2010US20100222324 Substituted Indole Compounds
09/02/2010US20100222310 Benzodiazepine compositions for treating epidermal hyperplasia and related disorders
09/02/2010US20100222309 Skin property-improving therapeutic agent comprising a morphinan derivative or any of its pharmacologically permissible acid addition salts as an active ingredient
09/02/2010US20100222305 Complexes of phosphate derivatives
09/02/2010US20100222274 Glycosylation-deficient hepatocyte growth factor
09/02/2010US20100222258 TNF antagonist and TNF inhibitor containing it as an effective ingredient
09/02/2010US20100222253 Methods for extracting platelets and compositions obtained therefrom
09/02/2010US20100221372 Wolfberries and skin inflammation
09/02/2010US20100221369 Natural hair care composition, methods for obtaining the same and use thereof
09/02/2010US20100221350 Dermatological compositions comprising vitamin d lipid vesicles
09/02/2010US20100221340 Method and compositions for treatment or prevention of inflammatory conditions
09/02/2010US20100221331 Pharmaceutical compositions comprising colloidal silicon dioxide
09/02/2010US20100221330 Buoyant formulations of betaine
09/02/2010US20100221319 Compositions and Methods for Improved Skin Care
09/02/2010US20100221318 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
09/02/2010US20100221310 Medical products including modified extracellular matrix materials
09/02/2010US20100221302 Delivery System For Heparin-Binding Growth Factors
09/02/2010US20100221300 Processing of Angiogenic Scaffolds for Large Organ Regeneration
09/02/2010US20100221231 Skin replacement compositions and methods
09/02/2010US20100221221 N-phenyl-2-pyrimidineamine derivatives
09/02/2010US20100221210 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
09/02/2010US20100221195 Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
09/02/2010US20100221194 Topical foam composition
09/02/2010US20100221179 IL-1 Binding Proteins
09/02/2010US20100221178 Method for Treating the TH2-Mediated Disease
09/02/2010CA2790906A1 Composition and methods for clotting blood
09/02/2010CA2753604A1 Drug combinations containing pde4-inhibitors and nsaids
09/02/2010CA2753597A1 Drug combinations containing pde4-inhibitors and nsaids
09/02/2010CA2753497A1 Topical foam composition
09/02/2010CA2753330A1 Uses of nk receptor antagonists
09/02/2010CA2751296A1 Novel n-phenylacetamide derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010CA2751279A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, pharmaceutical and cosmetic compositions containing them
09/02/2010CA2751156A1 Visfatin therapeutic agents for the treatment of acne and other conditions
09/01/2010EP2223922A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
09/01/2010EP2223920A2 Substituted azabicyclic compounds
09/01/2010EP2223699A1 Radical therapeutic agent for keloid and hypertrophic scar
09/01/2010EP2223688A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof
09/01/2010EP2223687A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof
09/01/2010EP2222671A1 Oxadiazole derivatives active on sphingosine-1-phosphate (sip)
09/01/2010EP2222669A1 Oxadiazole derivatives active on sphingosine-1-phosphate (sip)
1 ... 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 ... 1065